These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 31450919)
1. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer. Akbari V; Kallhor M; Mollashahi B; Movafagh A Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919 [TBL] [Abstract][Full Text] [Related]
2. Identification of key genes and pathways involved in microsatellite instability in colorectal cancer. Yu C; Hong H; Zhang S; Zong Y; Ma J; Lu A; Sun J; Zheng M Mol Med Rep; 2019 Mar; 19(3):2065-2076. PubMed ID: 30664178 [TBL] [Abstract][Full Text] [Related]
3. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high. Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951 [TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients. Ak S; Tunca B; Yilmazlar T; Tezcan G; Cecener G; Egeli U; Ozturk E; Yerci O; Ertürk E; Zorluoglu A J Surg Res; 2013 Dec; 185(2):626-37. PubMed ID: 23992855 [TBL] [Abstract][Full Text] [Related]
5. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer. Lin A; Zhang J; Luo P Front Immunol; 2020; 11():2039. PubMed ID: 32903444 [TBL] [Abstract][Full Text] [Related]
6. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer. Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726 [TBL] [Abstract][Full Text] [Related]
7. Association of Microsatellite Instability and Gene Expression Profile in Colorectal Carcinoma and Potential Implications for Therapy. Kibriya MG; Jasmine F; Khamkevych Y; Raza M; Kamal M; Bissonnette M; Ahsan H Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541076 [No Abstract] [Full Text] [Related]
8. Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1. Li X; Li X; Liao D; Wang X; Wu Z; Nie J; Bai M; Fu X; Mei Q; Han W Curr Protein Pept Sci; 2015; 16(4):301-9. PubMed ID: 25929864 [TBL] [Abstract][Full Text] [Related]
9. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E Digestion; 2004; 69(3):166-76. PubMed ID: 15118395 [TBL] [Abstract][Full Text] [Related]
10. Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients. Johansen AFB; Kassentoft CG; Knudsen M; Laursen MB; Madsen AH; Iversen LH; Sunesen KG; Rasmussen MH; Andersen CL BMC Cancer; 2019 Oct; 19(1):971. PubMed ID: 31638937 [TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer. Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208 [TBL] [Abstract][Full Text] [Related]
12. RNA methylation-related genes INHBB and SOWAHA are associated with MSI status in colorectal cancer patients and may serve as prognostic markers for predicting immunotherapy efficacy. Yin Y; Yang S; Huang Z; Yang Z; Zhang C; He Y Carcinogenesis; 2024 May; 45(5):337-350. PubMed ID: 38400766 [TBL] [Abstract][Full Text] [Related]
13. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy. Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906 [TBL] [Abstract][Full Text] [Related]
15. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Carr PR; Alwers E; Bienert S; Weberpals J; Kloor M; Brenner H; Hoffmeister M Ann Oncol; 2018 Apr; 29(4):825-834. PubMed ID: 29438474 [TBL] [Abstract][Full Text] [Related]
16. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array. Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652 [TBL] [Abstract][Full Text] [Related]
17. Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer. Ali H; Bitar MS; Al Madhoun A; Marafie M; Al-Mulla F PLoS One; 2017; 12(2):e0171690. PubMed ID: 28231327 [TBL] [Abstract][Full Text] [Related]
18. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications. Marginean EC; Melosky B Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791 [TBL] [Abstract][Full Text] [Related]
19. Mutational and expressional analysis of MLL genes in gastric and colorectal cancers with microsatellite instability. Je EM; Lee SH; Yoo NJ; Lee SH Neoplasma; 2013; 60(2):188-95. PubMed ID: 23259788 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma. Srdjan M; Jadranka A; Ivan D; Branimir Z; Daniela B; Petar S; Velimir M; Zoran K Indian J Med Res; 2016 May; 143(Supplement):S104-S111. PubMed ID: 27748284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]